Skip to main content

Table 1 Baseline characteristics of the 50 patients

From: High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial

 

ALL N = 50

Age (years), median (IQR)

71.50 (56.75; 79.25)

Gender, male n (%)

30 (60.0)

Dialysis vintage (months), median (IQR)

47.0 (26.5; 110.5)

Diabetes, n (%)

18 (36.0)

Hypertension, n (%)

38 (76.0)

Smoking, n (%)

8 (16.0)

Calcification score, median (IQR)

7.0 (2.0; 13.25)

Baseline dp-ucMGP (pM), median (IQR)

3179.15 (1825.25; 4339.50)

NCBB, n (%)

20 (40.0)

Residual diuresis, n (%)

6 (12.0)

Calcium dose (tablets of 600 mg), median (IQR)

1.00 (1.00; 2.25)

Alfacalcidol dose (μg), median (IQR)

0.75 (0.00; 1.50)

Serum phosphate (mg/dl), median (IQR)

3.90 (3.17; 4.65)

Serum calcium (mg/dl), median (IQR)

9.10 (8.80; 9.30)

PTH (pg/ml), median (IQR)

188.50 (117.75; 266.50)

LDL cholesterol (mg/dl), median (IQR)

92.0 (77.0; 113.0)

BMI (Kg/m2), median (IQR)

25.82 (22.85; 28.42)

URR, median (IQR)

75.0 (71.0; 79.0)

Albumin (g/l), median (IQR)

39.0 (36.0; 41.0)

CAD, n (%)

14 (28.0)

Cinacalcet, n (%)

2 (4.0)

Previous acenocoumadin, n (%)

6 (12.0)

PTHX, n (%)

2 (4.0)

Recent fracture, n (%)

3 (6.0)

  1. Abbreviations: NCBB non-calcium-based phosphate binders, PTH intact parathyroid hormone, BMI body mass index, URR urea reduction ratio, CAD documented coronary artery disease, PTHX previous parathyroidectomy